One of the most high-profile international collaborations on tackling the coronavirus pandemic is the ACT Accelerator, a global initiative by government leaders, health organizations, businesses and philanthropic bodies that aims accelerate the development and production of COVID-19 treatments, vaccines and tests and to make them available on an equitable basis.
Several companies have made commitments to allocate some of the worldwide supplies of coronavirus products to the ACT Accelerator since...








